首页 | 本学科首页   官方微博 | 高级检索  
检索        

头颈部鳞癌的分子靶向治疗的临床应用进展
引用本文:周霞东,包景峰,关泉林.头颈部鳞癌的分子靶向治疗的临床应用进展[J].医学综述,2010,16(7).
作者姓名:周霞东  包景峰  关泉林
作者单位:1. 兰州大学第一临床医学院,兰州,730000;兰州大学第一医院肿瘤外科,兰州,730000
2. 兰州大学第二临床医学院,兰州,730000
摘    要:分子靶向治疗为头颈部鳞癌(SCCHN)的治疗提供了新的手段,它能够特异性地作用于肿瘤发生、发展中起关键作用的靶分子及其调控的信号转导通路,从而达到治疗肿瘤的目的。在SCCHN分子靶向治疗的临床试验中,靶向表皮生长因子受体、血管内皮细胞生长因子和多靶点抑制剂的药物治疗已经显示出了潜在的疗效和良好的发展前景。

关 键 词:头颈部癌  分子靶向治疗  临床进展

Molecular Targeted Therapy in Advanced Head and Neck Cancer
ZHOU Xia-dong,BAO Jing-feng,GUAN Quan-lin,..Molecular Targeted Therapy in Advanced Head and Neck Cancer[J].Medical Recapitulate,2010,16(7).
Authors:ZHOU Xia-dong    BAO Jing-feng  GUAN Quan-lin  
Institution:ZHOU Xia-dong1,2,BAO Jing-feng3,GUAN Quan-lin1,2.(1.The First Clinical Medical College of Lanzhou University,Lanzhou 730000,China,2.Department of Oncological Surgery,the First Hospital of Lanzhou University,3.The Second Clinical Medical College of Lanzhou University,China)
Abstract:New approaches targeting molecular abnormalities specific to squamous cell carcinoma of the head and neck(SCCHN)has offered a new method to improve patient outcome.The increasing knowledge in the molecular pathogenesis of SCCHN as well as the introduction of molecular targeted therapies in oncology has created an encouraging trend in the management of this malignancy.Early studies of targeted therapies for SCCHN,including targeting the EGFR pathway and inhibiting angiogenesis and multikinase inhibitors,have...
Keywords:Squamous cell carcinoma of the head and neck  Molecular targeted therapy  Clinical progress  
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号